Build practical AI literacy skills for regulatory affairs through hands-on exercises and group discussions. Learn where AI can add value, understand its risks, and apply it responsibly across the regulatory lifecycle.
Artificial Intelligence is rapidly transforming the way regulatory professionals access information, generate content, analyze data, and support decision-making. Yet successful adoption requires more than simply knowing which AI tools exist. It requires AI literacy: an understanding of how these technologies work, where they can add value, their limitations, and how to use them responsibly within regulated environments.
AI Literacy Lab: A Hands-On Workshop for Regulatory Professionals is an interactive, full-day workshop designed to help regulatory professionals build practical AI skills that can be immediately applied to their daily work. Through demonstrations, guided exercises, group discussions, and real-world regulatory case studies, participants will explore how AI can support activities across the product lifecycle, from pre-submission planning through regulatory submissions, agency interactions, and post-market change control activities.
By the end of this workshop, participants will be able to:
Alcon Johns Creek – Commons Building (look for ‘Contact Café’ sign)
11460 Johns Creek Pkwy
Johns Creek, GA 30097
Directions and Parking:
Alcon Johns Creek encompasses several buildings and parking lots. To ensure you arrive at the correct location, please use the street address: 11460 Johns Creek Pkwy, Duluth, GA 30097.
Building and check in information:
The event will be hosted in the Johns Creek Commons building. Look for the exterior sign marked "Contact Cafe" to identify the correct building. A visual map is provided as an attachment for your convenience, detailing the building's location within the campus. Please locate the RAPS table adjacent to the building's entrance to check in upon your arrival.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].




CEO & Co-founder, NyquistAI
Michelle Wu is the founder and CEO of NyquistAI. She has over a decade of experience in pharmaceuticals, medical technology, and digital innovation. She has been recognized as the Top 100 Women in AI in 2025, featured by Forbes, and given talks on AI in life science in various conferences. She is a book chapter author for AI in Healthcare by MIT Press.
Before founding NyquistAI, she was the youngest global strategy manager at Novartis AG, where she worked on the very first and so far the only asset swap deal in the history of the pharmaceutical industry among Novartis, Eli Lilly, and GSK, which led her to realize the universal pain point of manual and cumbersome data research and potential pitfalls if it is not done right. This experience inspired her to build NyquistAI. Prior to Novartis, she worked for the life science practice for BCG and served big innovative pharmaceutical and Medtech companies on their global strategy, product development strategy, and emerging market strategies. She received her MBA from Stanford University and BA from Peking University.

Associate Product & Strategy Director, IQVIA Regulatory Intelligence
No bio provided

Regulatory Intelligence & Strategy, Hologic
Geethapriya (Priya) Setty is a regulatory affairs strategist and systems builder with a deep belief in purpose-driven innovation. With over a nine years of experience in global regulatory affairs and more than decade in healthcare, she brings a unique blend of clinical insight and policy expertise to the evolving world of medical technology. Starting her career as an occupational therapist, Priya’s focus has always been on impact- adding life to years, not just years to life. Today, she leads regulatory intelligence and digital transformation initiatives at a global medical device company, where she designs scalable systems to track emerging regulations, accelerate compliance, and enable access to life-changing technologies. Her work includes spearheading the development of an AI-powered Regulatory Intelligence platform that cut manual effort by 94 percent and brought real-time insights to global regulatory teams. She has also led the enterprise-wide implementation of a global Regulatory Information Management platform, driving requirements gathering, process alignment, and change management to standardize regulatory data and submissions across her organization. She has supported cross-functional teams in advancing regulatory strategies for high-risk and breakthrough devices, contributed to early responses to policies like the EU AI Act and FDA's evolving digital health guidance, and partnered across R&D, clinical, and quality functions to help build compliance into innovation from day one. Priya holds dual MBAs and is certified in RAC (Devices), PMP, ISO 13485 auditing, and medical device compliance. She thrives at the intersection of technology, policy, and strategy, and is known for her ability to bring clarity to complexity. Her mantra "make a choice, and make it happen" guides how she leads, builds, and mentors. Whether supporting teams through regulatory change or architecting AI-enabled solutions, she remains grounded in the mission that first drew her to healthcare: to serve, to simplify, and to make healthcare innovation more human.